Track: CME Session
Track: Hybrid Session
Daniela Castro, MS
City of Hope Comprehensive Cancer Center
Duarte, California, United States
Disclosure(s): No financial relationships to disclose
Elaine Chang, MD
United States Food and Drug Administration
Disclosure(s): No financial relationships to disclose
Chung-Han Lee, BS, PhD, MD
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Disclosure(s): Contract Research: BMS (Ongoing); Calithera (Ongoing); Eisai (Ongoing); Eli Lilly (Ongoing); Exelixis (Ongoing); Merck (Ongoing); Pfizer (Ongoing)
Non-CE Consulting: AiCME (Ongoing); Amgen (Ongoing); Aveo (Ongoing); BMS (Ongoing); Eisai (Ongoing); EMD Serono (Ongoing); Exelixis (Ongoing); Ideology Health (Ongoing); Intellisphere (Ongoing); Merck (Ongoing); Pfizer (Ongoing); Research to Practice (Ongoing)
Sumanta Pal, FASCO
City of Hope
Duarte, California, United States
Disclosure(s): No financial relationships to disclose
Laura Wood, RN, MSN, OCN
Retired, Cleveland Clinic Cancer Center
Medina, Ohio, United States
Disclosure(s): Non-CE Speakers Bureau: Aveo (Ongoing); Bristol Meyers Squibb (Ongoing); Eisai (Ongoing); EMD Serono (Ongoing); Exelixis (Ongoing); Merck (Ongoing); Pfizer (Ongoing)
Speaker: Sumanta Kumar Pal, FASCO – City of Hope
Speaker: Elaine Chang, MD – United States Food and Drug Administration
Speaker: Chung-Han Lee, BS, PhD, MD – Memorial Sloan Kettering Cancer Center
Speaker: Laura S. Wood, RN, MSN, OCN – Retired, Cleveland Clinic Cancer Center
Oral Abstract Presenter: Daniela V. Castro, MS – City of Hope Comprehensive Cancer Center